Search icon

CREOSALUS INC.

Company claim

Is this your business?

Get access!

Company Details

Name: CREOSALUS INC.
Legal type: Kentucky Corporation
Status: Active
Standing: Good
Profit or Non-Profit: Profit
File Date: 06 Oct 2004 (21 years ago)
Organization Date: 06 Oct 2004 (21 years ago)
Last Annual Report: 03 Apr 2024 (a year ago)
Organization Number: 0596573
Industry: Engineering, Accounting, Research, Management & Related Services
Number of Employees: Medium (20-99)
ZIP code: 40204
City: Louisville
Primary County: Jefferson County
Principal Office: 1044 EAST CHESTNUT STREET, LOUISVILLE, KY 40204
Place of Formation: KENTUCKY
Authorized Shares: 10001000

President

Name Role
David Y. Phelps President

Director

Name Role
David Y. Phelps Director

Incorporator

Name Role
FBT LLC Incorporator

Registered Agent

Name Role
LAUREN KIPLE Registered Agent

Unique Entity ID

Unique Entity ID:
CBL5M5DKH3K7
CAGE Code:
5Y6M4
UEI Expiration Date:
2025-12-10

Business Information

Activation Date:
2024-12-12
Initial Registration Date:
2009-12-03

Central Index Key

CIK number:
0001309632
Phone:
5023153200

Latest Filings

Form type:
REGDEX
File number:
021-71348
Filing date:
2004-11-22
File:

Commercial and government entity program

CAGE number:
5Y6M4
Status:
Active
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-12-12
CAGE Expiration:
2029-12-12
SAM Expiration:
2025-12-10

Contact Information

POC:
DAVID Y. PHELPS

Form 5500 Series

Employer Identification Number (EIN):
201722864
Plan Year:
2023
Number Of Participants:
28
Sponsors Telephone Number:
Plan Year:
2023
Number Of Participants:
62
Sponsors Telephone Number:
Plan Year:
2022
Number Of Participants:
66
Sponsors Telephone Number:
Plan Year:
2021
Number Of Participants:
66
Sponsors Telephone Number:
Plan Year:
2020
Number Of Participants:
78
Sponsors Telephone Number:

Permits

Agency Interest Id Program Activity Type Current Milestone Issued Date Milestone Date
5699 Water Resources Floodplain New Approval Issued 2019-08-26 2019-08-26
Document Name Permit # 29279P.pdf
Date 2020-07-02
Document Download

Former Company Names

Name Action
THORN NEWCO, INC. Old Name

Filings

Name File Date
Annual Report 2024-04-03
Registered Agent name/address change 2023-10-26
Registered Agent name/address change 2023-06-01
Annual Report 2023-04-18
Annual Report 2022-06-28

USAspending Awards / Contracts

Procurement Instrument Identifier:
HHSN261201400056P
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
9999.20
Base And Exercised Options Value:
9999.20
Base And All Options Value:
9999.20
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2013-11-21
Description:
IGF::OT::IGF CREOSALUS - TETRAS SERVICE WARRANTY AND MAINTENANCE AGREEMENT (LAST 10 MONTHS OF FY'14; DEC. 4, 2013 - OCT. 3, 2014 COVERS ONE PM VISIT, TRAVEL DUE TO EQUIPMENT FAILURE, PARTS, LABER, TIME, SOFTWARE UPDATES, TECHNICAL SUPPORT)
Naics Code:
811219: OTHER ELECTRONIC AND PRECISION EQUIPMENT REPAIR AND MAINTENANCE
Product Or Service Code:
J066: MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT
Procurement Instrument Identifier:
HHSN261201000275P
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
86500.00
Base And Exercised Options Value:
86500.00
Base And All Options Value:
86500.00
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2010-04-20
Description:
TAS::75 0849::TAS THURAMED TETRAS
Naics Code:
339112: SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING
Product Or Service Code:
6515: MED & SURGICAL INSTRUMENTS,EQ & SUP
Procurement Instrument Identifier:
HHSN267200801182P
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
31500.00
Base And Exercised Options Value:
31500.00
Base And All Options Value:
31500.00
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2008-09-28
Description:
INDIVIDUAL DELIVER STATIONS, 15 (POSITION #36)
Naics Code:
334516: ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Product Or Service Code:
6640: LABORATORY EQUIPMENT AND SUPPLIES

USAspending Awards / Financial Assistance

Date:
2024-08-26
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
COMPARISON OF CONVECTION ENHANCED DELIVERY SYSTEMS IN A RANDOMIZED CONTROLLED CLINICAL STUDY OF RECURRENT GRADE 3-4 GLIOMA PATIENTS - PROJECT ABSTRACT SIGNIFICANCE: THE DEVASTING OUTCOMES FOR GLIOBLASTOMA (GBM) PATIENTS REMAIN DESPITE THE ADVANCES IN CANCER THERAPY. IMPROVED GBM THERAPY AS A CRITICAL UNMET NEED REQUIRES NEW INTERVENTION CAPABILITIES AND THE LIKELY INTEGRATION OF INNOVATIVE GBM INTERVENTIONS AS PROPOSED WITH THIS RESEARCH. THE PREMISE OF THIS PROJECT IS THAT ONE OF THE CHALLENGES TO IMPROVING GBM PATIENT LIVES CAN BE OVERCOME BY INCREASED THERAPEUTIC COVERAGE OF GBM TUMORS USING AN INNOVATIVE CONVECTION ENHANCED DELIVERY (CED) CATHETER. INNOVATIONS: THE PROPOSED SBIR DIRECT TO PHASE II RESEARCH OFFERS THE INNOVATIONS OF (1) IMPROVED GBM THERAPEUTIC AGENT DELIVERY OBTAINED WITH THE CED POROUS BRAIN INFUSION CATHETER (PBIC) WHEN COMBINED WITH A MORE ACCURATE MOLECULAR FLOW SIMULATIONS (MFS) SOFTWARE – AS THE PBIC SYSTEM AND, (2) A NOVEL APPROACH TO EVALUATE CED DRUG DELIVERY CATHETERS WITH A RANDOMIZED CONTROLLED TRIAL. PRELIMINARY DATA: PBIC HAS DEMONSTRATED PRECLINICAL IN VIVO INCREASED VOLUME OF INFUSED BRAIN DISTRIBUTION. THE MFS INFUSION PLANNING SOFTWARE HAS DEMONSTRATED ROBUST CORRELATION OF ACTUAL AND SIMULATED HUMAN BRAIN TUMOR INFUSIONS AND HAS OBTAINED FDA 510K MARKETING CLEARANCE. COMPARATIVE GBM TUMOR INFUSION SIMULATIONS USING THE FDA CLEARED MFS SOFTWARE INDICATE PBIC CAN INCREASE THERAPEUTIC COVERAGE OF GBM TUMORS. HYPOTHESIS: THE PBIC WILL HAVE EQUIVALENT OR IMPROVED SAFETY PROFILE AND SIGNIFICANTLY GREATER PERCENTAGE OF ENHANCING TUMOR COVERAGE THAN AN END PORT CED CATHETER. OVERALL PROJECT OBJECTIVE: ACCELERATE CED RESEARCH WITH THE CLINICAL SAFETY AND INFUSION DISTRIBUTION EVALUATION OF THE PBIC SYSTEM IN AIM 1 RESEARCH. SPECIFIC AIM 1: FIRST-IN-HUMAN STUDY TO EVALUATE PBIC SAFETY AND RECURRENT GBM TUMOR INFUSION DISTRIBUTION EFFICACY. CREOSALUS WILL MANUFACTURE PBIC TEST DEVICES AND PROVIDE PHYSICIAN PLACEMENT TRAINING. DUKE INVESTIGATORS WITH THERATAXIS SUPPORT WILL EVALUATE THE PBIC TO TREAT RECURRENT WHO GRADE 3 OR 4 MALIGNANT GLIOMA (RGBM) PATIENTS, USING AN EXISTING DUKE CLINICAL TRIAL OF INTRATUMORAL THERAPEUTIC INFUSION VIA CED OF D2C7-IT AND 2141-V11 (NCT04547777, IND 151390). A TOTAL OF 24 PATIENTS (12 PATIENTS PER CATHETER GROUP) WILL BE RANDOMIZED TO EITHER THE PBIC OR THE CURRENT DUKE CED END PORT CATHETER. SAFETY ANALYSIS WILL BE BASED ON CATHETER RELATED ADVERSE EVENTS. INFUSION DISTRIBUTION IN ENHANCING TUMOR WILL BE EVALUATED WITH CO-INFUSED PET IMAGING TRACERS (124I-HUMAN SERUM ALBUMIN (HSA)) SAME AS USED IN PRIOR DUKE BRAIN TUMOR CENTER AND THERATAXIS CED DISTRIBUTION STUDIES. AIM 1 MILESTONE: COMPARED TO THE CONTROL END PORT CATHETER THE PBIC WILL DEMONSTRATE (A) EQUIVALENT OR BETTER SAFETY AND (B) SIGNIFICANTLY IMPROVED (P<.05) 124I-HSA DISTRIBUTION IN ENHANCING TUMOR. RESEARCH IMPACT: IMPROVED DRUG DISTRIBUTION USING A CATHETER SPECIFICALLY DESIGNED FOR CED TO IMPROVE GBM AND OTHER BRAIN DISEASE/INJURY PATIENT OUTCOMES.
Obligated Amount:
857315.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-01-25
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
1098449.00
Total Face Value Of Loan:
1098449.00
Date:
2020-05-05
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
1098450.00
Total Face Value Of Loan:
1098450.00
Date:
2020-05-05
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
-1098450.00
Total Face Value Of Loan:
0.00
Date:
2019-08-31
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
CATHETER FOR LARGE VOLUME INTRAPARENCHYMAL BRAIN THERAPIES
Obligated Amount:
2992280.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks

Serial Number:
77490550
Mark:
AIM PHARMA
Status:
Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2008-06-04
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
AIM PHARMA

Goods And Services

For:
Manufacturing services for others in the field of Pharmaceutical Packaging
International Classes:
040 - Primary Class
Class Status:
ACTIVE
Serial Number:
77468996
Mark:
AMPS
Status:
Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2008-05-08
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
AMPS

Goods And Services

For:
Computer software for controlling asynchronous multiple peptide synthesis
International Classes:
009 - Primary Class
Class Status:
ACTIVE
Serial Number:
77468038
Mark:
TETRAS
Status:
The registration has been renewed.
Mark Type:
Trademark
Application Filing Date:
2008-05-07
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
TETRAS

Goods And Services

For:
Scientific apparatus, namely, apparatus for automated synthesis of peptides
First Use:
2006-03-03
International Classes:
009 - Primary Class
Class Status:
ACTIVE

Paycheck Protection Program

Jobs Reported:
97
Initial Approval Amount:
$1,098,449
Date Approved:
2021-01-25
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$1,098,449
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$1,104,979.51
Servicing Lender:
Morgantown Bank & Trust Company, Inc.
Use of Proceeds:
Payroll: $1,098,446
Utilities: $1
Jobs Reported:
49
Initial Approval Amount:
$1,098,450
Date Approved:
2020-05-05
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$1,098,450
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$1,104,137.66
Servicing Lender:
Morgantown Bank & Trust Company, Inc.
Use of Proceeds:
Payroll: $1,029,500
Healthcare: $68950

Reviews Leave a review

This company hasn't received any reviews.

Financial Incentive

Program Program Status Average Hourly Wage Project Cost Incentive Amount Initial Jobs New Jobs Date of Action Approval Type
SBIR/STTR Active - $149,699 $149,699 - - 2022-07-01 Final
HTP - High-Tech Pool Inactive 38.46 $1,250,000 $750,000 20 41 2007-07-26 Final
GIA/BSSC Inactive 37.50 $0 $27,200 22 12 2006-12-01 Final
KIDA - Kentucky Industrial Development Act Inactive 32.04 $800,000 $610,000 0 30 2006-10-26 Final

Sources: Kentucky Secretary of State